TGF-β acts as a tumor suppressor by inhibiting proliferation and inducing apoptosis during the early stages of tumorigenesis [16], whereas it is considered a tumor promoter in advanced CRC. This evidence concerns the gene TGFB1 and colorectal carcinoma.